Nightingale Health Oyj (HEL:HEALTH)

Market Cap	53.24M -64.2%
Revenue (ttm)	5.50M +17.2%
Net Income	-18.47M
EPS	-0.30
Shares Out	60.36M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,105
Open	0.8760
Previous Close	0.8700
Day's Range	0.8760 - 0.9040
52-Week Range	0.7860 - 2.6600
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 16, 2026

About Nightingale Health Oyj

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2002
• Employees: 101
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: HEALTH

Financial Performance

In fiscal year 2026, Nightingale Health Oyj's revenue was 5.50 million, an increase of 17.24% compared to the previous year's 4.69 million. Losses were -18.47 million, 0.06% more than in 2025.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 23, 2026

Data Sources Report a data error